DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition

A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer

(2017) Momeneh Foroutan et al.   MOLECULAR CANCER RESEARCH

Concurrent Hypermethylation of SFRP2 and DKK2 Activates the Wnt/β-Catenin Pathway and Is Associated with Poor Prognosis in Patients with Gastric Cancer

(2017) Hao Wang et al.   MOLECULES AND CELLS

Correlation of RUNX3 expression with microvessel density in colorectal adenocarcinoma tissues and clinical significance

(2017) Jun Xue et al.   Asian Pacific Journal of Tropical Medicine

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection

(2017) Shomyseh Sanjabi et al.   Cold Spring Harbor Perspectives in Biology

TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research

(2017) Takehiko Yokobori et al.   Journal of Clinical Medicine

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients

(2017) Mia Møller et al.   Scientific Reports

MMP-14 and TGFβ-1 methylation in pituitary adenomas

(2016) Kornelija Ruskyte et al.   Oncology Letters

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

(2016) Roberta Melchionna et al.   OncoImmunology

DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma

(2014) Brittany N Lasseigne et al.   BMC Medicine

RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma

(2013) Feifei Chen et al.   PLoS One

RUNX3 Mediates Suppression of Tumor Growth and Metastasis of Human CCRCC by Regulating Cyclin Related Proteins and TIMP-1

(2012) Lijie He et al.   PLoS One

Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-β signal transduction

(2010) Motoshi Mabuchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Associations between genetic variation in RUNX1 , RUNX2 , RUNX3 , MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathway

(2010) Martha L. Slattery et al.   CARCINOGENESIS